API reference

Sodium phenylbutyrate

CAS number
1716-12-7
Molecular formula
C10H11NaO2
Molecular weight
186.18 g/mol
Sodium phenylbutyrate — 2D structure
2D structure (PubChem)

About this molecule

Phenylbutyrate and sodium benzoate are orphan drugs approved for the treatment of hyperammonemia in patients with urea cycle disorders, a series of at least 8 rare genetic enzyme deficiencies. The urea cycle is the major pathway of elimination of excess nitrogen including ammonia, and absence of one of the urea cycle enzymes often causes elevations in serum ammonia which can be severe, life-threatening and result in permanent neurologic damage and cognitive deficiencies. Both phenylbutyrate and sodium benzoate act by promoting an alternative pathway of nitrogen elimination. Neither phenylbutyrate nor sodium benzoate have been linked to cases of liver injury either in the form of serum enzyme elevations during therapy or clinically apparent acute liver injury.

Source: LiverTox, via PubChem.

Identifiers

IUPAC name
sodium 4-phenylbutanoate
InChIKey
VPZRWNZGLKXFOE-UHFFFAOYSA-M
SMILES
C1=CC=C(C=C1)CCCC(=O)[O-].[Na+]
PubChem CID
5258

Also known as

Sodium 4-phenylbutyrate · SODIUM PHENYLBUTYRATE · Buphenyl · TriButyrate · Benzenebutanoic acid, sodium salt · Ammonaps · Pheburane · 4-phenylbutyric acid, sodium salt

Chemical data on this page is drawn from PubChem (National Library of Medicine) and is provided for identification only. Hanpars does not hold stock of every substance listed; availability, grade, documentation and regulatory status are confirmed per enquiry.

Tell us the grade, the quantity and the market.

Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.

Telephone+98 21 8888 3325 · office hours 09:00–17:00, Tehran
OfficeHaniya Parsan Darou, 3rd floor, No. 326, Zafar Street, Africa Boulevard, Tehran 1968734974, Iran
Emailcontact@hanpars.com